Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Active Pregnancy Against COVID-19

  • Read more about Active Pregnancy Against COVID-19

COVID-19 Serology and Immunosenescence

  • Read more about COVID-19 Serology and Immunosenescence

Physiopathology and Sequelae of COVID-19 Infection

  • Read more about Physiopathology and Sequelae of COVID-19 Infection

Comorbidities And Complications Associated With Covid-19 Infection

  • Read more about Comorbidities And Complications Associated With Covid-19 Infection

Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

  • Read more about Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

  • Read more about Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans

  • Read more about Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans

Telerehabilitation in Lung Surgery Patients

  • Read more about Telerehabilitation in Lung Surgery Patients

Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

  • Read more about Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population

  • Read more about Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • Current page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA